The histaminergic system as a target for the prevention of obesity and metabolic syndrome.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Neuropharmacology

• Publication date

  2016-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.neuropharm.2015.07.002PMID 26164344
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Heterogeneity of Histaminergic Neurons

  2016cited by this paper
• The histamine H4 receptor: from orphan to the clinic

  2015cited by this paper
• Potential role of glutathione in evolution of thiol-based redox signaling sites in proteins

  2015cited by this paper
• International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors

  2015influential reference
• Histamine in the basolateral amygdala promotes inhibitory avoidance learning independently of hippocampus

  2015cited by this paper
• Years of life lost and healthy life-years lost from diabetes and cardiovascular disease in overweight and obese people: a modelling study.

  2015cited by this paper
• International Union of Basic and Clinical Pharmacology. XCVII. G Protein–Coupled Estrogen Receptor and Its Pharmacologic Modulators

  2015influential reference
• Preventing Olanzapine-Induced Weight Gain Using Betahistine: A Study in a Rat Model with Chronic Olanzapine Treatment

  2014influential reference
• The effects of antipsychotic switching on diabetes in chronic schizophrenia

  2014cited by this paper
• H1-antihistamines exacerbate high-fat diet-induced hepatic steatosis in wild-type but not in apolipoprotein E knockout mice.

  2014cited by this paper
• Hypothalamic histamine H1 receptor-AMPK signaling time-dependently mediates olanzapine-induced hyperphagia and weight gain in female rats.

  2014cited by this paper
• Betahistine ameliorates olanzapine-induced weight gain through modulation of histaminergic, NPY and AMPK pathways.

  2014influential reference
• Satiety factor oleoylethanolamide recruits the brain histaminergic system to inhibit food intake

  2014cited by this paper
• Chronic Ingestion of H1-Antihistamines Increase Progression of Atherosclerosis in Apolipoprotein E-/- Mice

  2014cited by this paper
• Histidine Augments the Suppression of Hepatic Glucose Production by Central Insulin Action

  2013cited by this paper
• The Role of Hypothalamic H1 Receptor Antagonism in Antipsychotic-Induced Weight Gain

  2013cited by this paper
• Antagonism of histamine H4 receptors exacerbates clinical and pathological signs of experimental autoimmune encephalomyelitis

  2013cited by this paper
• Selective brain region activation by histamine H₃ receptor antagonist/inverse agonist ABT-239 enhances acetylcholine and histamine release and increases c-Fos expression.

  2013cited by this paper
• The histaminergic network in the brain: basic organization and role in disease

  2013cited by this paper
• Bicyclic and tricyclic heterocycle derivatives as histamine H3 receptor antagonists for the treatment of obesity.

  2013cited by this paper
• The satiety signal oleoylethanolamide stimulates oxytocin neurosecretion from rat hypothalamic neurons.

  2013cited by this paper
• Reducing olanzapine-induced weight gain side effect by using betahistine: a study in the rat model

  2012cited by this paper
• Activation of rat intestinal mucosal mast cells by fat absorption.

  2012cited by this paper
• Involvement of the capsular genu in reward-related feeding

  2012influential reference
• Recent Advances in Understanding and Mitigating Adipogenic and Metabolic Effects of Antipsychotic Drugs

  2012cited by this paper
• Contribution of the TRPV1 channel to salt taste quality in mice as assessed by conditioned taste aversion generalization and chorda tympani nerve responses.

  2012cited by this paper
• Integrative role of the histaminergic system in feeding and taste perception

  2012cited by this paper
• Automated diagnoses of attention deficit hyperactive disorder using magnetic resonance imaging

  2012cited by this paper
• Histamine neurons in the tuberomamillary nucleus: a whole center or distinct subpopulations?

  2012cited by this paper
• Histamine and neuroinflammation: insights from murine experimental autoimmune encephalomyelitis

  2012cited by this paper
• Reducing antipsychotic-induced weight gain in schizophrenia: a double-blind placebo-controlled study of reboxetine–betahistine combination

  2012influential reference
• Proxyfan acts as a neutral antagonist of histamine H3 receptors in the feeding‐related hypothalamic ventromedial nucleus

  2012cited by this paper
• Atypical antipsychotics and the neural regulation of food intake and peripheral metabolism.

  2011cited by this paper
• The Histamine H3 Receptor and Eating Behavior

  2011cited by this paper
• l‐Dopa activates histaminergic neurons

  2011cited by this paper
• Deprivation of anticipated food under scheduled feeding induces c-Fos expression in the caudal part of the arcuate nucleus of hypothalamus through histamine H₁ receptors in rats: potential involvement of E3 subgroup of histaminergic neurons in tuberomammillary nucleus.

  2011cited by this paper
• Histamine receptors in the CNS as targets for therapeutic intervention.

  2011cited by this paper
• Association between the ROBO1 gene and body mass index in patients using antipsychotics

  2011cited by this paper
• Histamine regulation in glucose and lipid metabolism via histamine receptors: model for nonalcoholic steatohepatitis in mice.

  2010cited by this paper
• The histaminergic tuberomammillary nucleus is critical for motivated arousal

  2010cited by this paper
• Acute effects of betahistine hydrochloride on food intake and appetite in obese women: a randomized, placebo-controlled trial.

  2010cited by this paper
• Association of Prescription H1 Antihistamine Use With Obesity: Results From the National Health and Nutrition Examination Survey

  2010cited by this paper
• The effect of hardness of food on amygdalar histamine release in rats.

  2010cited by this paper
• Effects of Betahistine at Histamine H3 Receptors: Mixed Inverse Agonism/Agonism In Vitro and Partial Inverse Agonism In Vivo

  2010cited by this paper
• The Fat-Induced Satiety Factor Oleoylethanolamide Suppresses Feeding through Central Release of Oxytocin

  2010cited by this paper
• Neuronal histamine and its receptors: implication of the pharmacological treatment of obesity.

  2010cited by this paper
• 5-hydroxyindole-2-carboxylic acid amides: novel histamine-3 receptor inverse agonists for the treatment of obesity.

  2009cited by this paper
• Activation of the histaminergic H3 receptor induces phosphorylation of the Akt/GSK‐3β pathway in cultured cortical neurons and protects against neurotoxic insults

  2009cited by this paper
• The Role of Thermogenesis in Antipsychotic Drug‐induced Weight Gain

  2009influential reference
• Orexin/Hypocretin and Histamine: Distinct Roles in the Control of Wakefulness Demonstrated Using Knock-Out Mouse Models

  2009cited by this paper
• Altered histamine H3 receptor radioligand binding in post‐mortem brain samples from subjects with psychiatric diseases

  2009cited by this paper
• Heterogeneity of histaminergic neurons in the tuberomammillary nucleus of the rat

  2009cited by this paper
• Acute central administration of immepip, a histamine H3 receptor agonist, suppresses hypothalamic histamine release and elicits feeding behavior in rats.

  2009cited by this paper
• Effect of histaminergic manipulation on weight in obese adults: a randomized placebo controlled trial

  2008cited by this paper
• Comparison of the effect of an H(3)-inverse agonist on energy intake and hypothalamic histamine release in normal mice and leptin resistant mice with high fat diet-induced obesity.

  2008cited by this paper
• Short- and long-term effects of antipsychotic drug treatment on weight gain and H1 receptor expression.

  2008cited by this paper
• Betahistine: what's new on the agenda?

  2008cited by this paper
• Histamine in the nervous system.

  2008cited by this paper
• The Akt/GSK-3beta axis as a new signaling pathway of the histamine H(3) receptor.

  2007cited by this paper
• Antagonistic targeting of the histamine H3 receptor decreases caloric intake in higher mammalian species.

  2007cited by this paper
• The Akt/GSK‐3β axis as a new signaling pathway of the histamine H3 receptor

  2007cited by this paper
• Histamine controls food intake in sheep via H1 receptors

  2007cited by this paper
• From the Cover: Antipsychotic drug-induced weight gain mediated by histamine H1 receptor-linked activation of hypothalamic AMP-kinase.

  2007cited by this paper
• Evidence for tolerance following repeated dosing in rats with ciproxifan, but not with A-304121.

  2006cited by this paper
• Fasting duration influences the inhibition of food intake by histamine in chickens.

  2006cited by this paper
• Betahistine: a retrospective synopsis of safety data.

  2006cited by this paper
• Histaminergic Neurons Are Involved in the Orexigenic Effect of Orexin-A

  2006cited by this paper
• The hypothalamic H1 receptor: a novel therapeutic target for disrupting diurnal feeding rhythm and obesity.

  2006cited by this paper
• Increase of Neuronal Histamine in Obese Rats Is Associated with Decreases in Body Weight and Plasma Triglycerides

  2006cited by this paper
• Specific activation of histaminergic neurons during daily feeding anticipatory behavior in rats.

  2005cited by this paper
• Histamine inhibits dopamine release in the mouse striatum via presynaptic H3 receptors

  2005cited by this paper
• Histamine H1 receptors in schizophrenic patients measured by positron emission tomography.

  2005cited by this paper
• Assessment of pharmacology and potential anti-obesity properties of H3 receptor antagonists/inverse agonists

  2005cited by this paper
• The effect of betahistine, a histamine H1 receptor agonist/H3 antagonist, on olanzapine-induced weight gain in first-episode schizophrenia patients

  2005cited by this paper
• Histamine‐immunoreactive neurons in the mouse and rat suprachiasmatic nucleus

  2005influential reference
• Hypothalamic histamine release by taste stimuli in freely moving rats: possible implication of palatability.

  2005cited by this paper
• Antipsychotic‐induced weight gain

  2005cited by this paper
• The histamine H3 receptor: from gene cloning to H3 receptor drugs

  2005cited by this paper
• Influence of a selective histamine H3 receptor antagonist on hypothalamic neural activity, food intake and body weight

  2005cited by this paper
• Corrigendum to acute wake‐promoting actions of JNJ‐5207852, a novel, diamine‐based H3 antagonist

  2005cited by this paper
• Hypothalamic neuronal histamine regulates sympathetic nerve activity and expression of uncoupling protein 1 mRNA in brown adipose tissue in rats.

  2004cited by this paper
• L-histidine stimulates sympathetic nerve activity to brown adipose tissue in rats.

  2004cited by this paper
• Histidine supplementation suppresses food intake and fat accumulation in rats.

  2004cited by this paper
• Antiobesity effects of A-331440, a novel non-imidazole histamine H3 receptor antagonist.

  2004cited by this paper
• Central H3R activation by thioperamide does not affect energy balance.

  2004cited by this paper
• Acute wake‐promoting actions of JNJ‐5207852, a novel, diamine‐based H3 antagonist

  2004cited by this paper
• Histamine H3 Receptors Inhibit Serotonin Release in Substantia Nigra Pars Reticulata

  2004influential reference
• In vitro optimization of structure activity relationships of analogues of A-331440 combining radioligand receptor binding assays and micronucleus assays of potential antiobesity histamine H3 receptor antagonists.

  2004cited by this paper
• Involvement of hypothalamic histamine H1 receptor in the regulation of feeding rhythm and obesity.

  2004cited by this paper
• The histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders.

  2004influential reference
• Drug induced weight gain, an impediment to successful pharmacotherapy: focus on antipsychotics.

  2004cited by this paper
• AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus

  2004cited by this paper
• H1-Histamine Receptor Affinity Predicts Short-Term Weight Gain for Typical and Atypical Antipsychotic Drugs

  2003cited by this paper
• Histamine receptors: specific ligands, receptor biochemistry, and signal transduction.

  2002cited by this paper
• Histidine Suppresses Food Intake through Its Conversion into Neuronal Histamine

  2002cited by this paper
• Binding affinity profile of betahistine and its metabolites for central histamine receptors of rodents.

  2001cited by this paper
• Feeding, drinking, and temperature responses of chickens to intracerebroventricular histamine.

  2001cited by this paper
• Central infusion of histamine reduces fat accumulation and upregulates UCP family in leptin-resistant obese mice.

  2001cited by this paper
• Histaminergic control of oxytocin release in the paraventricular nucleus during lactation in rats.

  2001cited by this paper
• Histamine and Betahistine in the Treatment of Vertigo

  2001influential reference

• Effects of Age and BMI on Histamine H3 Receptor Availability in Healthy Humans

  2025cites this paper
• Betahistine Normalizes the State of Mitochondria in Deiters Neurons during Vestibular Stimulation

  2025cites this paper
• Brain histaminergic system: an emerging target for the treatment of feeding and eating-related disorders.

  2025cites this paper
• Histaminergic System Activity in the Central Nervous System: The Role in Neurodevelopmental and Neurodegenerative Disorders

  2024cites this paper
• Mechanisms Involved in the Link between Depression, Antidepressant Treatment, and Associated Weight Change

  2024cites this paper
• The Effect of KSK-94, a Dual Histamine H3 and Sigma-2 Receptor Ligand, on Adipose Tissue in a Rat Model of Developing Obesity

  2024cites this paper
• Urinary Metabolite Profiles of Participants with Overweight and Obesity Prescribed a Weight Loss High Fruit and Vegetable Diet: A Single Arm Intervention Study

  2024cites this paper
• Targeting histamine in metabolic syndrome: Insights and therapeutic potential.

  2024cites this paper
• Influence of the gut microbiota on satiety signaling.

  2023cites this paper
• Olanzapine manipulates neuroactive signals and may onset metabolic disturbances

  2023cites this paper
• Consumo de Frutose Altera Aminas Biogênicas Associadas a Fatores de Risco Cardiovasculares

  2023cites this paper
• Histaminergic regulation of food intake

  2023cites this paper
• Betahistine prevents development of endolymphatic hydrops in a mouse model of insulin resistance and diabetes

  2023cites this paper
• Histamine H3 receptor antagonists - Roles in neurological and endocrine diseases and diabetes mellitus.

  2022cites this paper
• The Diverse Network of Brain Histamine in Feeding: Dissect its Functions in a Circuit-Specific Way

  2022cites this paper
• Dual Targeting Ligands—Histamine H3 Receptor Ligands with Monoamine Oxidase B Inhibitory Activity—In Vitro and In Vivo Evaluation

  2022cites this paper
• New Chemical Biology Tools for the Histamine Receptor Family.

  2022cites this paper
• Histamine H1‐ and H2‐receptors participate to provide metabolic energy differently

  2022cites this paper
• Meclizine and Metabotropic Glutamate Receptor Agonists Attenuate Severe Pain and Ca2+ Activity of Primary Sensory Neurons in Chemotherapy-Induced Peripheral Neuropathy

  2022cites this paper
• The Case for Clinical Trials with Novel GABAergic Drugs in Diabetes Mellitus and Obesity

  2022cites this paper
• Influence of betahistine repeated administration on a weight gain and selected metabolic parameters in the model of excessive eating in rats.

  2021cites this paper
• Current strategies for predicting side effects from second generation antipsychotics in youth

  2021cites this paper
• Different Peas in the Same Pod: The Histaminergic Neuronal Heterogeneity.

  2021cites this paper
• Efficacy and Safety of Non-brain Penetrating H1-Antihistamines for the Treatment of Allergic Diseases.

  2021cites this paper
• Targeting Histamine and Histamine Receptors for the Precise Regulation of Feeding.

  2021cites this paper
• A Duet Between Histamine and Oleoylethanolamide in the Control of Homeostatic and Cognitive Processes.

  2021cites this paper
• Meclizine and metabotropic glutamate receptor agonists attenuate severe pain and primary sensory neuron Ca2+ activity in chemotherapy-induced peripheral neuropathy

  2021cites this paper
• The Intestinal Perspective of COVID-19: NOS2 and AOC1 Genes as Epidemiological Factors, and a Homeopathic Approach to their Functional Improvement

  2020cites this paper
• Effects of probiotic supplementation on gut microbiota as well as metabolite profiles within Nile tilapia, Oreochromis niloticus

  2020cites this paper
• From Gut to Brain: a pas de deux between oleoylethanolamide and neuronal histamine

  2020cites this paper
• Benefits and Adverse Effects of Histidine Supplementation.

  2020cites this paper
• Histamine and Obesity: Do Histamine and Histidine Injections Increase Body Weight and Adipose Tissue Mass?

  2019cites this paper
• Mast Cell-Derived Histamine Regulates Liver Ketogenesis via Oleoylethanolamide Signaling.

  2019cites this paper
• Novel Tetrahydroquinazolinamines as Selective Histamine 3 Receptor Antagonists for the Treatment of Obesity.

  2019cites this paper
• Histamine H3 receptor antagonists/inverse agonists: Where do they go?

  2019cites this paper
• KSK19 - novel histamine H3 receptor ligand reduces body weight in diet induced obese mice.

  2019cites this paper
• Is Neuronal Histamine Signaling Involved in Cancer Cachexia? Implications and Perspectives

  2019cites this paper
• Histaminergic neurotransmission as a gateway for the effects of the fat sensing molecule Oleoylethanolamide

  2019cites this paper
• Neuronal histamine and the memory of emotionally salient events

  2018cites this paper
• Progress in the development of histamine H3 receptor antagonists/inverse agonists: a patent review (2013-2017)

  2018cites this paper
• Non-Imidazole Histamine H3 Ligands. Part VII. Synthesis, In Vitro and In Vivo Characterization of 5-Substituted-2-thiazol-4-n-propylpiperazines

  2018cites this paper
• The current state of GPCR‐based drug discovery to treat metabolic disease

  2018cites this paper
• 4-Hydroxypiperidines and Their Flexible 3-(Amino)propyloxy Analogues as Non-Imidazole Histamine H3 Receptor Antagonist: Further Structure–Activity Relationship Exploration and In Vitro and In Vivo Pharmacological Evaluation

  2018cites this paper
• Prevention and Treatment of Obesity and Metabolic Dysfunction in Children with Major Behavioral Disorders: Second-Generation Antipsychotics

  2018cites this paper
• Does Armodafinil Improve Driving Task Performance and Weight Loss in Sleep Apnea? A Randomized Trial

  2018cites this paper
• The histamine H3 receptor inverse agonist pitolisant reduces body weight in obese mice

  2018influential citation
• Histamine H1 Receptor Contributes to Vestibular Compensation

  2018cites this paper
• Brain histamine modulates recognition memory: possible implications in major cognitive disorders

  2018cites this paper
• β-Eudesmol, an oxygenized sesquiterpene, stimulates appetite via TRPA1 and the autonomic nervous system

  2017cites this paper
• Evaluation of Histidine Decarboxylase (HDC) Activity and Human Histamine Receptor 3 (H 3 R) and HDC mRNA Levels

  2017cites this paper
• Antipsychotic Drugs: From Receptor-binding Profiles to Metabolic Side Effects

  2017cites this paper
• Activation of the ileal neuroendocrine tumor cell line P-STS by acetylcholine is amplified by histamine: role of H3R and H4R

  2017cites this paper
• Histaminergic Neurotransmission as a Gateway for the Cognitive Effect of Oleoylethanolamide in Contextual Fear Conditioning

  2017cites this paper
• Role of histamine in the regulation of intestinal immunity in fish.

  2016cites this paper
• DOTTORATO DI RICERCA IN AREA DEL FARMACO E TRATTAMENTI INNOVATIVI

  2016cites this paper
• Histamine in diabetes: Is it time to reconsider?

  2016cites this paper
• Heterogeneity of Histaminergic Neurons

  2016cites this paper
• The Endocannabinoid-Like Derivative Oleoylethanolamide at the Gut–Brain Interface: A “Lipid Way” to Control Energy Intake and Body Weight

  2016cites this paper
• Role of betahistine in glycemic control of obese subjects: a placebo- controlled clinical trial

  2016cites this paper
• Role of the Histamine H3 Receptor in the Central Nervous System.

  2016cites this paper
• Histamine: The Missing Link in the Pathogenesis of Some Brain Disorders

  2016cites this paper
• Ameliorating antipsychotic-induced weight gain by betahistine: Mechanisms and clinical implications.

  2016cites this paper
• Monoaminergic and Histaminergic Strategies and Treatments in Brain Diseases

  2016cites this paper
• Eating disorders: from bench to bedside and back

  2016cites this paper
• Histamine H3 receptors and its antagonism as a novel mechanism for antipsychotic effect: a current preclinical & clinical perspective.

  2016cites this paper
• Genetic Polymorphisms in the Histamine Receptor Family

  2016cites this paper
• The hypophagic factor oleoylethanolamide differentially increases c-fos expression in appetite regulating centres in the brain of wild type and histamine deficient mice.

  2016cites this paper
• Histamine and Appetite

  2016cites this paper
• Histamine receptors.

  2016cites this paper
• Histamine receptors

  year unknowncites this paper
• An Overview of Antipsychotics: Mechanisms of Action

  year unknowncites this paper